Investigación original / Original research
Panam Salud Publica. 2016;39(1):38–43.
Harm Reduction Journal (2016) 13:28
DOI 10.1186/s12954-016-0118-x
Towards gender - transformative HIV and TB responses
Journal of Virus Eradication 2016; 2 (Supplement 4): 1–6
Review
A Booklet on Women and HIV/AIDS for Auxiliary Nurse Midwives (ANMs) Accredited Social Health Activists (ASHAs) Anganwadi Workers (AWWs) and Members of Self-help Groups (SHGs)
Version 2
Guidance | Preparedness - Response and early recovery - Recovery and reconstruction
Report of a mission 20–24 April 2015
Meeting report
Geneva, 16-18 November 2016
PLoSONE 12(9):e0184986.https://doi.org/10.1371/journal.pone.0184986
PLOS Medicine | DOI:10.1371/journal.pmed.1002088 August 23, 2016
World Health Organization Department of Reproductive Health and Research
Brocher Foundation, Hermance, Geneva, Switzerland, 27–29 April 2016
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s...tandardised questionnaires and the Global TB Drug Facility website.
more
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
Research Article
PLOS Medicine | DOI:10.1371/journal.pmed.1002253 April 4, 2017
Thirty-three years after its discovery, the Human Immunodeficiency Virus (HIV), responsible for the AIDS pandemic, remains a major public health problem despite advanced researches providing better diagnostic and therapeutic tools. The virus targets especially CD4+ T cells, leading to deficiency of ...the immune system and altering therefore defense against infections and cancer cells. Antiretroviral
more